paxilline has been researched along with Cancer of Larynx in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Gong, L; Li, L; Wang, J | 1 |
| Chen, G; Feng, Y; Gao, W; Huangfu, H; Wang, B; Wen, S; Zhang, C | 1 |
| Chen, GG; Feng, Y; Gao, W; Huangfu, H; Wang, BQ; Wen, SX; Zhang, CM; Zhang, S | 1 |
3 other study(ies) available for paxilline and Cancer of Larynx
| Article | Year |
|---|---|
Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paxillin; Prognosis; Survival Rate | 2015 |
Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Blotting, Western; Carcinoma, Squamous Cell; Carrier Proteins; Cytoskeletal Proteins; Female; Humans; Immunohistochemistry; Laryngeal Neoplasms; Male; Microfilament Proteins; Middle Aged; Paxillin; Reverse Transcriptase Polymerase Chain Reaction; Young Adult | 2012 |
[Expressions of key molecules affiliated cytoskeleton in laryngeal squamous cell carcinoma and their implications for prognosis].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Carrier Proteins; Cytoskeletal Proteins; Cytoskeleton; Female; Humans; Laryngeal Neoplasms; Male; Microfilament Proteins; Middle Aged; Neoplasm Recurrence, Local; Paxillin; Prognosis | 2012 |